Clinical management of breast cancer heterogeneity

D Zardavas, A Irrthum, C Swanton… - Nature reviews Clinical …, 2015 - nature.com
… Traditionally, intertumour heterogeneity in breast cancer has been documented in terms
of different histological subtypes, treatment sensitivity profiles, and clinical outcomes among …

Biomarkers for the clinical management of breast cancer: international perspective

N Patani, LA Martin, M Dowsett - International journal of cancer, 2013 - Wiley Online Library
… These phenotypes approximate to the major intrinsic subtypes of breast cancer defined
by cluster analysis of global gene expression profiles.9, 10 In clinical practice, subtype …

Performance of FDG PET/CT in the clinical management of breast cancer

D Groheux, M Espié, S Giacchetti, E Hindié - Radiology, 2013 - pubs.rsna.org
In this analysis, the role of metabolic imaging with fluorine 18 fluorodeoxyglucose (FDG) in
breast cancer is reviewed. The analysis was limited to recent works by using state-of-the-art …

Clinical management of women with metastatic breast cancer: a descriptive study according to age group

K Manders, LV van de Poll-Franse, GJ Creemers… - BMC cancer, 2006 - Springer
… The objectives of the current study are to describe and quantify the clinical management of
women with metastatic breast cancer from the diagnosis of metastatic disease until death and …

Male breast cancer: a review of clinical management

A Agrawal, AA Ayantunde, R Rampaul… - Breast cancer research …, 2007 - Springer
… Male breast cancer incidence is 1% of all breast cancers and is increasing. We aim to …
an overview of male breast cancer with particular emphasis on clinical management. …

The role of diffuse optical spectroscopy in the clinical management of breast cancer

N Shah, AE Cerussi, D Jakubowski, D Hsiang… - Disease …, 2004 - Wiley Online Library
Diffuse optical spectroscopy (DOS) of breast tissue provides quantitative, functional information
based on optical absorption and scattering properties that cannot be obtained with other …

Luminal B breast cancer: molecular characterization, clinical management, and future perspectives

F Ades, D Zardavas, I Bozovic-Spasojevic… - Journal of clinical …, 2014 - ascopubs.org
Gene expression profiling has reshaped our understanding of breast cancer by defining
and characterizing four main intrinsic molecular subtypes: human epidermal growth factor …

Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

E Luporsi, F André, F Spyratos, PM Martin… - Breast cancer research …, 2012 - Springer
… factor or a predictive factor in women with breast cancer. The terms used for searching
were divided into three groups to identify references on: breast cancer and its treatment, Ki-67 …

Clinical management of breast pain: a review

AV Millet, FM Dirbas - Obstetrical & gynecological survey, 2002 - journals.lww.com
… Careful evaluation to rule out breast cancer and reassure the patient is enough to make
the pain resolve in most cases. In a few patients, however, mastalgia is severe enough to …

[HTML][HTML] … consensus on the clinical management of inflammatory breast cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th …

NT Ueno, JRE Fernandez, M Cristofanilli… - … of Cancer, 2018 - ncbi.nlm.nih.gov
… MD Anderson Cancer Center in Houston Texas. A consensus on the clinical management
of … using the MDRing electronic survey on key management issues. A summary of the expert …